Recap of the Week: Pharmaceuticals, Biogen, Pfizer mixed performance

This week shares of Pfizer Inc. PFE, +0.14%, crawled 0.14% higher to USD34.89. Overall, this was a  great trading session for the stock market, as the S&P 500 Index SPX rose 1.09% to 3,871.74 and the Dow Jones Industrial Average DJIA went up 1.08% to 31,055.86.

The stock’s rise was a sharp snap to the three-day losing streak. Meanwhile, Pfizer Inc. Closed its exchange at USD8.19 beneath its 52-week high, USD43.08.

This week the stock market showed quite a mixed performance, e.g., Johnson and Johnson JNJ rose 0.93% to USD161.99, Merck and Co. Inc. MRK, – 1.67% fell 1.67% to USD76.03, and Novartis AG ADR NVS, +1.44% rose 1.44% to USD90.63.

Catalyst Pharmaceuticals Inc. stock underperforms this week.

This week was full of surprises.  Catalyst Pharmaceuticals Inc. CPRX, quite a strong market contender,  – slipped 5.37% to USD4.23.  Compared to some of its competitors Thursday, the stock underperformed as Johnson & Johnson JNJ, +0.93% rose 0.93% to USD161.99, Pfizer Inc. PFE +0.14% rose 0.14% to USD 34.89. Abbott Laboratories ABT, – 0.40% fell 0.40% to USD119.74. Trading volume (2.3 M) overshadowed its 50-day normal volume of 1.9 M.

Catalyst Pharmaceuticals Inc. closed USD1.05 below its 52-week high (USD5.28), which the company reached on February 20th. 

Biogen Inc. stock rises and outperforms the market.

Shares of Biogen Inc. BIIB, +1.57% mobilized 1.57% to USD267.39 this Thursday.  That was an all-around favorable trading session for the stock market. In fact, the S&P 500 Index SPX rose 1.09% to 3,871.74, and the Dow Jones Industrial Average DJIA went up 1.08% to 31,055.86. The stock’s ascent snapped a three-day losing streak. Biogen Inc. shut USD96.53 shy of its 52-week high (USD363.92), which the organization came to on November fourth.

Moreover, the stock outperformed some of its competitors, like Johnson and Johnson JNJ, +0.93% rose 0.93% to USD161.99, Pfizer Inc. PFE, went up 0.14% to USD34.89, and AbbVie Inc. ABBV, +1.48% rose 1.48% to USD108.53. Trading volume eclipsed its 50-day average volume of 1.3 M.